WeVote
Log In

Bill

KB

Bill

HR 149

A resolution to declare July 21–25, 2025, as Fibroids Awareness Week in the state of Michigan.

2025-2026 Regular Session Introduced by Kelly Breen and 13 co-sponsors

Designates July 21–25, 2025 as Michigan Fibroids Awareness Week to raise awareness, promote education and early diagnosis, and recognize advocates; no new policy.

adopted
0
WeVote Research Nonpartisan
Bill Summary · HR 149

Summary — House Resolution 149 (Fibroids Awareness Week — Michigan)

Status: Adopted (ceremonial resolution)
Primary sponsor: Rep. Morgan Foreman
Subject: Declares July 21–25, 2025, as “Fibroids Awareness Week” in Michigan

Purpose

HR 149 is a non‑binding, ceremonial House resolution designating July 21–25, 2025, as Fibroids Awareness Week in the state of Michigan. Its aim is to raise public awareness about uterine fibroids, highlight their health impacts and disparities, encourage early diagnosis and research, and recognize the role of community advocates and health professionals in supporting affected individuals.

Key provisions

  • Formally declares July 21–25, 2025 as Fibroids Awareness Week in Michigan.
  • Recites findings (whereas clauses) about uterine fibroids, including:
    • Fibroids (leiomyomas/myomas) are noncancerous uterine tumors that can affect up to 70% of women by age 50.
    • Incidence is highest among African American women.
    • Symptoms can include heavy menstrual bleeding, pelvic pain, frequent urination, fatigue, anemia, infertility, and pregnancy complications.
    • Fibroids are a leading cause of hysterectomy in the U.S.
    • There are gaps in awareness, funding, research, and access to treatment — particularly in underserved and minority communities.
  • Encourages residents to learn about fibroids and support people affected by the condition.
  • Recognizes the contributions of community advocates, healthcare professionals, and nonprofit organizations in education, outreach, and advocacy.

Who is affected / intended beneficiaries

  • Primarily women of reproductive age in Michigan, with particular emphasis on African American women and those in underserved communities who face higher prevalence and barriers to care.
  • Healthcare providers, advocacy groups, and community organizations that provide education, screening, treatment, and support services.

Procedural notes and effect

  • Classification: House resolution (ceremonial). It does not create new legal obligations, appropriations, or regulatory changes.
  • Legislative record (selected): introduced in the House by Rep. Foreman; adopted by the House (recorded roll call noted in legislative actions). The resolution is intended to raise public awareness and encourage community and institutional responses, but any policy, funding, or programmatic changes would require separate legislation or appropriations.

Potential impact

Short term — raises visibility of uterine fibroids, promotes education and early diagnosis, and validates advocacy efforts.
Long term — may spur policymakers, health systems, and funders to consider targeted research, screening, prevention, or treatment initiatives, but the resolution itself carries no binding mandates or funding. Related measure: HCR 154 (companion).

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.